Biosimilars and implications for pharmacy practice: Ready or not, here they come!
Andrea L. Hobbs1★, Joshua P. Crawford2★ Corresponding author
- 1PharmD, Transitions of Care Clinical Specialist and Pharmacy Residency Coordinator, Bon Secours Memorial Regional Medical Center, Mechanicsville, VA, United States.
- 2PharmD, BCPS, System Director Clinical Pharmacy Services, Bon Secours Mercy Health, Cincinnati, OH, United States.
CORRESPONDENCE
Andrea L. Hobbs
PharmD, Transitions of Care Clinical Specialist and Pharmacy Residency Coordinator, Bon Secours Memorial Regional Medical Center, Mechanicsville, VA, United States.
Received: 19-08-2019; Accepted: 26-08-2019.
Volume 17, Issue 3 · pp. 1659 · PUBLISHED 29 August 2019 · DOI: 10.18549/PharmPract.2019.3.1659
ABSTRACT
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Hobbs, A. L., & Crawford, J. P. (2019). Biosimilars and implications for pharmacy practice: Ready or not, here they come!. Pharmacy Practice, 17(3), 1659. https://doi.org/10.18549/PharmPract.2019.3.1659
